Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.53
-0.50 (-3.84%)
At close: Jul 10, 2026, 4:00 PM EDT
12.81
+0.28 (2.23%)
After-hours: Jul 10, 2026, 7:53 PM EDT
Tonix Pharmaceuticals Holding Employees
Tonix Pharmaceuticals Holding had 142 employees as of December 31, 2025. The number of employees increased by 61 or 75.31% compared to the previous year.
Employees
142
Change (1Y)
61
Growth (1Y)
75.31%
Revenue / Employee
$123,634
Profits / Employee
-$1,037,930
Market Cap
199.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | 61 | 75.31% |
| Dec 31, 2024 | 81 | -22 | -21.36% |
| Dec 31, 2023 | 103 | -14 | -11.97% |
| Dec 31, 2022 | 117 | 44 | 60.27% |
| Dec 31, 2021 | 73 | 47 | 180.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Humacyte | 184 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Caribou Biosciences | 97 |
| Immunic | 95 |
| Tenaya Therapeutics | 70 |
| Acumen Pharmaceuticals | 61 |
TNXP News
- 10 days ago - Tonix Pharmaceuticals Holding Slides: Investor presentation - Filings
- 12 days ago - Tonix Pharmaceuticals enrolls first patient in HORIZON study - TheFly
- 12 days ago - Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD) - GlobeNewsWire
- 16 days ago - Tonix Pharmaceuticals initiated with a Strong Buy at Raymond James - TheFly
- 26 days ago - Tonix Pharmaceuticals Holding Slides: Investor presentation - Filings
- 4 weeks ago - Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals secures second commercial agreement for Tonmya - TheFly
- 4 weeks ago - Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives - GlobeNewsWire